
This chapter outlines the clinician' s guide for prescription of benzodiazepine anxiolytics and 5-HT1A receptor agonists. 5-HT1A receptor agonists have entirely different pharmacological mechanism of action from benzodiazepines, and the pattern of their use is quite different from benzodiazepines. In the global trend, there are strict regulations for the prescription of benzodiazepines, because of the risk of low-dose dependence. Benzodiazepines are recommended for the use only when necessary in the short term. In contrast, benzodiazepines have many clinical indications, compared with 5-HT1A receptor agonists. In Japan, there is no strict regulation to prescription of benzodiazepines. However, we now tend to follow international trends in general.
Benzodiazepines, Anti-Anxiety Agents, Humans, Selective Serotonin Reuptake Inhibitors
Benzodiazepines, Anti-Anxiety Agents, Humans, Selective Serotonin Reuptake Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
